Susquehanna International Group
WHWK

Susquehanna International Group’s Whitehawk Therapeutics WHWK Stock Holding History

Susquehanna International Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
203,465
+93,382
+85% +$292K ﹤0.01% 8809
2025
Q4 		$266K Buy
+110,083
New +$253K ﹤0.01% 10234
2025
Q2 		– Sell
-52,486
Closed -$93.4K – 14002
2025
Q1 		$93.4K Sell
52,486
-5,025
-9% -$13.1K ﹤0.01% 11582
2024
Q4 		$181K Sell
57,511
-14,434
-20% -$32.7K ﹤0.01% 10833
2024
Q3 		$148K Sell
71,945
-27,986
-28% -$45.2K ﹤0.01% 10751
2024
Q2 		$146K Buy
99,931
+61,216
+158% +$113K ﹤0.01% 10722
2024
Q1 		$90.6K Buy
38,715
+7,273
+23% +$14K ﹤0.01% 11275
2023
Q4 		$63.5K Buy
31,442
+17,905
+132% +$75.1K ﹤0.01% 11608
2023
Q3 		$65.5K Sell
13,537
-7,298
-35% -$42.4K ﹤0.01% 11171
2023
Q2 		$143K Sell
20,835
-1,124
-5% -$8.74K ﹤0.01% 10625
2023
Q1 		$159K Buy
+21,959
New +$235K ﹤0.01% 10859
2022
Q3 		– Sell
-30,306
Closed -$398K – 14294
2022
Q2 		$373K Sell
30,306
-66,175
-69% -$983K ﹤0.01% 8971
2022
Q1 		$1.64M Buy
96,481
+74,524
+339% +$1.43M ﹤0.01% 5927
2021
Q4 		$530K Buy
+21,957
New +$551K ﹤0.01% 9031

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Susquehanna International Group's WHWK Position: Q1 2026 in Review

Susquehanna International Group increased its Whitehawk Therapeutics (WHWK) stake by 85% in Q1 2026, buying an estimated $292K and bringing the position to 203,465 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #8809.

Susquehanna International Group first reported a position in WHWK in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.64M in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Susquehanna International Group held 203,465 shares of Whitehawk Therapeutics worth $702K as of Q1 2026.
  • Susquehanna International Group bought 93,382 Whitehawk Therapeutics shares in Q1 2026, an estimated $292K.
  • Whitehawk Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8809 holding.
  • Susquehanna International Group first reported a position in Whitehawk Therapeutics in Q4 2021 and has held it in 14 quarters since.
  • Susquehanna International Group's Whitehawk Therapeutics position peaked at $1.64M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.